In commemoration of the 35th World AIDS Day themed "World AIDS Day 35: Remember and Commit," Chemonics reflects on three and a half decades of progress in the global fight against HIV/AIDS.
Chemonics has been honored to work at the forefront of the fight against HIV/AIDS through our health and supply chain flagship projects—the USAID Global Health Supply Chain Program–Procurement and Supply Management (GHSC–PSM) project, the USAID GHSC-Technical Assistance Francophone Task Order (GHSC-TA FTO), the Frontier Health Markets (FHM) Engage project, and the USAID Nigeria Strategic HIV/AIDS and TB Response Program (SHARP). Despite remarkable strides, our focus extends beyond delivering services—it's about breaking down stigma, fostering compassion worldwide, and putting communities and their needs in the forefront by letting them lead.
Join us this World AIDS Day in reflecting on milestones and committing to the ongoing journey. Let's remember lives touched, acknowledge persistent challenges, and commit anew to a future where HIV is no longer a threat. Together, with communities leading the way, Chemonics remains dedicated to empowering and making a lasting impact in the fight against HIV/AIDS.
Increasing the Number of Patients on ARV Treatment in Mozambique
In a country with a high incidence of HIV, ensuring the availability and accessibility of treatment is key to helping people living with HIV live happier, healthier lives. That is the case of Mozambique, where the Chemonics-led GHSC–PSM project has worked to increase the number of people receiving treatment. Learn more about these efforts and their impact in this short video featuring our GHSC–PSM Country Director in Mozambique, Dimitri Peffer. Mozambique isn’t the only place GHSC–PSM has been having profound impacts in the HIV/AIDS space – check out further videos from the Country Directors of Angola, Indonesia, and Liberia.
Commitment to Treatment
Differentiated service delivery (DSD) and MMD of HIV treatment have enhanced adherence and viral suppression. This study, funded by USAID through the Nigeria SHARP TO1 and TO3 projects led by Chemonics, explores the experiences of six DSD models among people living with HIV and health care providers across five states in northern Nigeria. Most found the models acceptable and satisfying, citing convenience, reduced stigma, increased trust, and reduced cost of care to patients. Both patients and providers noted improved adherence and viral suppression, though concerns about quality of care in community-based models were raised. Overall, DSD and MMD show promise in boosting patient retention rates and service delivery efficiency, as per the experiences shared.
Making Life-Saving HIV Treatment Accessible to Pregnant Women in ZAMBIA
In the journey to combat HIV/AIDS, initiatives in Zambia show progress. USAID, in partnership with the Zambian Government, provides crucial support for pregnant women living with HIV. Through the commitment of GHSC-PSM, individuals like Purity receive life-saving ARV treatment, ensuring access, reducing transportation costs, and contributing to saving over 1.2 million lives. Purity's story exemplifies the impact of early treatment and the importance of continued commitment to ending HIV/AIDS.
Additional resources
chemonics.com
LEARN MORE
HIV/AIDS commodities
delivered through GHSC–PSM
patient trips to pharmacy likely saved through multi-month dispensing (MMD) through GHSC–PSM
2.4M
person-years of ARV treatment delivered through GHSC–PSM
102M
<
66%
of adult patients in Togo now benefit
from MMD, as well as 77% of pediatric
patients thanks to GHSC-TA FTO
350K
patients served in DRC, where GHSC-TA FTO has secured 0% stockout of TLD at the central level for 3 years
stockouts at the central level in Togo and Benin, under GHSC-TA FTO, of HIV/AIDS commodities at PEPFAR sites, since January 2022
Technical Advisor, HIV Supply Chain, GHSC–PSM
—Sheriff Bangura
“Two decades ago, access to antiretrovirals for poor and vulnerable populations was deemed impossible. Through PEPFAR, the GHSC–PSM project has helped millions of people in over 40 countries receive HIV medications through strengthened supply chain systems in the public sector, contributing to millions of lives saved. Our collective role is to build on this legacy through renewed commitments and support toward ending HIV/AIDS.”
TO1 Director, GHSC–PSM
—Bonnie Medeossi
“I vividly remember the face of my first home-based care client on his death bed in Botswana with no access to ARVs. This was at a time when policies were getting in place at global and national levels yet weren’t reaching the people who needed them the most. Now, as part of GHSC–PSM, delivering HIV commodities to 59 counties, I am reminded daily of why we still need to continue pushing for equitable access to HIV care and treatment for all.”
Country Coordinator, Afya Ugavi
—Miriam Okara
“Life is about making an impact and World AIDS Day is a reminder that every person, every life, matters.”
Managing Director, Global Health Programs
Global Health Division, Chemonics
—Baz Semo
“To end the HIV epidemic by 2030, I believe what is needed is sustained global and political commitment at the country level, increased funding commitments including domestic financing, continued investments in HIV prevention, as well as commitments to uphold the human rights of marginalized communities and allow communities to lead and monitor the HIV response."
LEARN MORE
55%
0
LEARN MORE
HUMAN RESOURCES FOR HEALTH OPTIMIZATION TOOL FOR ART: HOT4ART
Comprehensive Agency Report on Condoms and Lubricants
Guidelines: A Network Approach to Scaling Up Laboratory Services
+
+
+
Strides Toward HIV
Epidemic Control in
Northern Nigeria
Manual: Supply Chain Considerations for Implementing Decentralized Drug Distribution
2022 GHSC–PSM
Annual Report
+
+
+
Strong Supply Chains: A Vital Link to HIV/AIDS Epidemic Control
HIV/AIDS 2023 by
the numbers
HRH2030’s Best Resources for the HIV Workforce
+
+
+
Subscribe
Let’s keep in touch
.
00
B
0
.
0
M
0
M
0
%
100
%
0
K
Differentiated Service Delivery Models for Treatment in Northern Nigeria:
A Discussion with Patients and Providers
Driving Last-Mile Solutions to Ensure Access to Public Health Commodities
The GHSC–PSM project ensures more equitable access to life-saving HIV prevention and treatment medicines and services. In a first-of-its-kind technical report, the project describes challenges and successes driving last mile solutions – from overcoming infrastructure and security challenges in Haiti (p. 26) to working with private pharmacies in Mozambique (p. 10). The project works with local partners to meet clients where they are, and GHSC–PSM promotes local ownership and private sector engagement to ensure last-mile sustainability, and implements innovative last-mile solutions to ensure access to public health commodities for those living in the most challenging circumstances.
LEARN MORE
.
0
M&E Specialist, GHSC–PSM Malawi
—Charles Nzawa
“By collaborating with the Malawi Ministry of Health and other supply chain stakeholders in continuous tracking, analysis, and reporting HIV commodities and data, the GHSC–PSM project has contributed to ensuring adequate and timely commodity quantification, procurement, and distribution planning for essential medicines and VMMC kits in support of PEPFAR’s strategic goal of accelerating the response to end the HIV/AIDS pandemic as a public health threat by 2030.”
LEARN MORE
In response to Russia's invasion of Ukraine, GHSC-PSM swiftly delivered over 200,000 bottles of life-saving antiretrovirals (ARVs) in just 27 days, a process that typically takes three months. Collaborating with partners like the Ukrainian NGO 100% Life, GHSC-PSM ensured uninterrupted access to ARVs for people living with HIV in war-torn regions. By the end of 2022, over 58 million ARVs, condoms, COVID-19 test kits, and diagnostic tests reached vulnerable people in Ukraine. This extraordinary effort, marked by global collaboration, exemplifies commitment to care amid adversity.
Ensuring Uninterrupted LIFE-SAVING HIV Care Amidst Ukraine's Crisis
LEARN MORE
This study, funded by USAID through the Nigeria SHARP TO1 and TO3 projects led by Chemonics, underscores the ongoing challenges in achieving UNAIDS 95-95-95 targets for children with HIV in Nigeria. While prevention and treatment efforts have reduced new infections, more than 40% of children with HIV globally remain undiagnosed. The study evaluates the impact of a Dolutegravir (DTG)-based regimen and MMD on viral suppression in Nigeria and shows MMD is a feasible strategy for scale up among the pediatric population because it does not compromise treatment outcomes for children. However, the study shows no conclusive evidence of improved suppression with DTG due to implementation strategies that favored switching patients already suppressed on other ART regimens. Adherence remains a critical barrier, emphasizing the need for comprehensive strategies to meet treatment targets for children with HIV in Nigeria.
Children with HIV: Determining the Impact of Multi-month Dispensing of Dolutegravir
In the fight against HIV/AIDS, committed health workers are the backbone of progress. Their unwavering dedication ensures timely testing, treatment, and support, reducing transmission and improving lives. Their compassion and resilience play a pivotal role in breaking down stigma, fostering understanding, and advancing the global mission to end the HIV/AIDS epidemic. Andela Emmanuel, a nurse in a GHSC–PSM-supported hospital in Yaoundé, Cameroon, works closely with people living with HIV. His passion for health care is evident, and we’re proud to collaborate with people like him who are so committed to seeing improved access to medication and health services in their communities.
Hope Means Change
Commitment to Care
2023
WORLD AIDS DAY
%
Photos by Toyin Adedokun, Andi Gultom, Mickael Breard, Bobby Neptune, Jennifer Moffatt, and Farmhouse.